MK-0616, an oral macrocyclic peptide PCSK9 inhibitor developed by Merck, demonstrated robust LDL-C reductions of up to 60.9% in Phase 2b trials and is now under NDA review ( JNJ-77242113, an oral IL-23 inhibitor macrocycle for psoriasis, and Luna-18, an oral macrocyclic peptide for metabolic indications, represent additional examples of this emerging class
How Tirzepatide Works Tirzepatide (the active ingredient in Mounjaro) is a dual agonist. It mimics two hormones: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
Pregnant women who received regular perinatal healthcare in the Outpatient Department of the Womens Hospital School of Medicine Zhejiang University and delivered in the hospital between June 2017 and April 2019 were recruited
A minimum of 3 weeks was allowed for recovery and transgene expression after surgery
Key safety risks include hypoglycaemia when combined with insulin or sulphonylureas, gastrointestinal interactions, pancreatitis, gallbladder disease, and dehydration-related acute kidney injury